HomeTargets › D2

D2 (1 companies · 6 programs)

Companies with an active program directed at D2.

REVIVA PHARMACEUTICALS HOLDINGS, INC. RVPH

  • brilaroxazine — Schizophrenia Phase 3
  • brilaroxazine — Bipolar Disorder
  • brilaroxazine — Major Depressive Disorder
  • brilaroxazine — Attention-Deficit/Hyperactivity Disorder
  • brilaroxazine — Behavioral and Psychotic Symptoms of Dementia
  • brilaroxazine — Parkinson's Disease Psychosis